Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma
Neuroblastoma (NBL) is a childhood malignancy of the sympathetic nervous system. For high-risk NBL patients, the mortality rate is still over 50%, despite intensive multimodal treatment. Anti-GD2 monoclonal antibody (mAB) in combination with systemic cytokine immunotherapy has shown clinical efficac...
Na minha lista:
Publicado no: | Oncoimmunology |
---|---|
Main Authors: | , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Taylor & Francis
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4938306/ https://ncbi.nlm.nih.gov/pubmed/27471639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1164919 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
A carregar...